Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
doi: 10.3389/fphys.2025.1734360 Received 28 October 2025 Revised 26 November 2025 Accepted 27 November 2025 Published 05 January 2026 Volume 16 - 2025 Edited by Sal A
Tirzepatide produced similar results at 2.1% reduction
INTRODUCTORY OFFER Claim Your $49$144 Offer
Berberine's extensive drug interaction profile makes it unsuitable for many individuals on polypharmacy, particularly those taking anticoagulants (e.g., warfarin), immunosuppressants (e.g., ciclosporin, tacrolimus), or medications with narrow therapeutic indices
Each compound brings unique strengths: glutathione handles cellular cleanup and detoxification, ergothioneine provides targeted mitochondrial protection, and PQQ stimulates the creation of new mitochondria
US$ 21.66
US$ 20.75
US$ 22.17
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 27.67
